LBLívia Bracht

Lívia Bracht

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lívia Bracht has a total of 132 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clove oil-derived β-caryophyllene carried in a self-nanoemulsifying drug delivery system improves adjuvant-induced arthritis in rats

    by Any Carolina Chagas, Ana Paula Ames-Sibin, Vanesa O Pateis, Luzmarina Hernandes, Juliana V C Martins-Perles, Marcos L Bruschi, Anacharis B Sá-Nakanishi, Lívia Bracht, Adelar Bracht, Francielli Maria S Silva-Comar, et al.

    Objectives: β-Caryophyllene (β-Cary) exhibits anti-inflammatory and antioxidant activities. It can be obtained from clove oil, which is rich in eugenol; following eugenol removal, β-Cary can be isolated as the major constituent. However, the high lipophilicity of β-Cary limits its oral bioavailability. The present study investigated the anti-arthritic effects of β-Cary formulated in a self-nanoemulsifying drug delivery system (β-SNEDDS) in Holtzman rats with complete Freund’s adjuvant-induced arthritis, emphasizing articular inflammation and systemic oxidative stress. Methods: Healthy and adjuvant-induced arthritic rats received oral β-Cary or β-SNEDDS (50 or 100 mg/kg). Treatments were administered by oral gavage for 18 days after arthritis induction. Paw oedema, arthritis severity score, and articular leucocyte infiltration were assessed. Cartilage and growth plate integrity were evaluated by histological and histomorphometric analyses of the knee joint. Oxidative stress parameters, mRNA expression of cytokines and cachexia-related MuRF1, plasma markers of liver injury, and hepatic gluconeogenesis were also evaluated. Key findings: β-SNEDDS exhibited greater anti-arthritic efficacy than non-formulated β-Cary. β-SNEDDS (100 mg/kg) reduced paw oedema and arthritis score while preserving cartilage structure, and downregulated TNF-α, IL-1β, IL-6, and MuRF1 mRNA expression in periarticular skeletal muscle. In addition, β-SNEDDS restored most oxidative stress parameters altered by arthritis. Although free β-Cary improved selected oxidative stress parameters, β-SNEDDS showed a broader protective profile. Neither β-Cary nor β-SNEDDS induced hepatotoxicity, as demonstrated by unchanged plasma markers of liver injury and hepatic gluconeogenesis in healthy rats. Conclusions: Nanoemulsification enhanced the oral anti-arthritic efficacy and antioxidant activity of β-caryophyllene, supporting β-SNEDDS as a promising strategy for rheumatoid arthritis.

  • Open Access

    Commercial Product Based on Metarhizium Anisopliae Affects Survival, Midgut Morphology, and Behavior in the Stingless Bee Scaptotrigona depilis (Hymenoptera: Apidae)

    by Andressa Santoro, Daiani Rodrigues Moreira, Talita Aparecida Tódora Santana, Wingly Santos Beltrame, Nathalia Rodrigues da Silva de Carvalho, Breno Gabriel da Silva, Gustavo Henrique de Souza, Livia Bracht, Adriana Aparecida Sinópolis Gigliolli, Maria Claudia Colla Ruvolo Takasusuki

    Brazilian social stingless bees are important pollinators and producers of honey, wax, royal jelly, propolis, and other products. These species are experiencing a population decline, attributed to different factors, such as the excessive use of pesticides. Biological control has been proposed as an alternative to chemical control, relying on the use of natural enemies to manage pests, including microorganisms such as entomopathogenic fungi. However, little is known about the effects of these agents on stingless bees. Therefore, this research evaluated the effect of the commercial bioproduct Metarhizium Oligos WP on the stingless bee Scaptotrigona depilis . After 5 and 10 days of exposure, the bees were cold‐immobilized and then dissected in saline solution, and the midgut was collected for histological and ultrastructural analyses. Injured organs were analyzed semiquantitatively. Additionally, superoxide dismutase (SOD) and catalase (CAT) activities were determined to investigate the occurrence of oxidative stress. Behavioral assessments were also performed. Although there were no significant changes in SOD and CAT activities, oxidative stress may have been induced, possibly due to the accumulation of reactive oxygen species and free radicals generated during fungal infection. These effects are believed to be the cause of the observed alterations in midgut morphology, as well as physiological and behavioral changes, such as impaired locomotion. The findings demonstrate the negative impact of the bioproduct on S. depilis stingless bees and suggest it may affect their pollination potential.

  • Improving the oral bioavailability and anti-inflammatory potential of clove oil-derived β-caryophyllene with a self-nanoemulsifying drug delivery system

    by Any Carolina Chagas-Almeida, Ana Paula Ames-Sibin, Juliana Cristina Castro, Sabrina Barbosa de Souza Ferreira, Tiane C Finimundy, Francielli Maria de Souza Silva, Anacharis Babeto de Sá-Nakanishi, Lívia Bracht, Lillian Barros, Adelar Bracht, et al.

    Objectives: β-Caryophyllene (β-Cary) is known for its anti-inflammatory properties and offers a promising avenue for drug development. This study prepared a lipid-based self-emulsifying system containing clove oil-derived β-Cary and investigated its bioavailability and anti-inflammatory effects upon oral administration in rats. Methods: The formulation (β-SNEDDS), composed of β-Cary, surfactant, and lipophilic phase, was evaluated as size, morphology, and rheology. Key findings: β-SNEDDS exhibited Newtonian flow and formed spherical droplets (≈100 nm) in water and phosphate-buffered saline (pH 6.8), with a diameter ~15% higher in PBS, likely due to ionic strength affecting surfactant hydration and interfacial structure. Transmission electron microscopy confirmed spherical particles in simulated gastrointestinal medium. β-SNEDDS showed twice the oral bioavailability of β-Cary. This phenomenon allowed β-SNEDDS to reduce carrageenan-induced paw edema and pleural polymorphonuclear leukocyte recruitment in the pleural cavity of rats, showing greater efficacy than β-Cary. Furthermore, β-Cary reduced N-Formyl-Met-Leu-Phe (fMLP)-induced leukocyte chemotaxis in vitro, and oral β-SNEDDS or β-Cary reduced rolling and adherent leukocytes in situ in rat microvascular endothelium. Notably, β-SNEDDS exhibited a more pronounced effect on rolling behavior. Conclusions: β-Cary showed significant anti-inflammatory activity by inhibiting leukocyte migration to the inflamed site. Its β-SNEDDS formulation improved oral bioavailability and additional anti-inflammatory parameters in vivo, beyond those achieved by β-Cary, supporting this approach as a promising oral strategy.


  • Open Access

    Short‐term actions of epigalocatechin‐3‐gallate in the liver: a mechanistic insight into hypoglycemic and potential toxic effects

    by Carla Indianara Bonetti, Bruna Lopes Correia, Francielle Cristina Nakamura Manicardi, Nairana Mithieli de Queiroz Eskuarek Melo, Vanesa de Oliveira Pateis, Jurandir Fernando Comar, Anacharis Babeto de Sá‐Nakanishi, Adelar Bracht, Lívia Bracht

    Epigallocatechin‐3‐gallate (EGCG), the main catechin in green tea, is associated with antidiabetic and anti‐obesity effects, although its acute hepatic actions remain unclear. We investigated short‐term effects of EGCG (10–500 μ m ) using isolated perfused rat livers and complementary assays in mitochondrial, microsomal, and cytosolic fractions. EGCG markedly inhibited gluconeogenesis from lactate (up to 52%), glycerol (33%), and alanine (47%), while it stimulated glycolysis, glycogenolysis, and oleic acid oxidation (+42% total ketone bodies). Oxygen uptake was stimulated under glycogenolytic and fatty acid oxidizing conditions but inhibited under gluconeogenic conditions. Mechanistic analyses revealed EGCG‐induced mild mitochondrial uncoupling, inhibition of pyruvate carboxylase and glucose‐6‐phosphatase (with no effect on fructose‐1,6‐bisphosphatase) and stimulation of phosphoenolpyruvate carboxykinase. EGCG shifted cytosolic and mitochondrial NADH/NAD + ratios toward oxidation, increased mitochondrial and plasma membrane permeability (LDH leakage from 10 μ m ), and altered redox‐sensitive fluxes, while the total hepatic ATP content remained unchanged. In summary, EGCG's multifaceted actions suggest that suppression of gluconeogenesis may contribute to its antihyperglycemic effect and the stimulation of fatty acid oxidation to its anti‐obesity action. Finally, EGCG's membrane‐disruptive properties raise concerns about potential hepatotoxicity in compromised livers.


  • An in vitro, in vivo and in silico assessment of fat absorption inhibition by a gymnemic acid rich extract of Gymnema sylvestre leaves

    by Thalita Faleiros Demito Santos, Gustavo H. Souza, Beatriz Paes Silva, Gabriel Arcanjo Viana Neto, Milena Thais Francisco Silva, Cristina Giatti Marques de Souza, Livia Bracht, Jurandir F. Comar, Rosane M. Peralta, Adelar Bracht, et al.


  • Tamarindus indica sub-products as potential tools for simultaneous management of diabetes and obesity

    by Gustavo Henrique Souza, Beatriz Paes Silva, Gabriel Arcanjo Viana Neto, Tiane C. Finimundy, Thalita Faleiro Demito Santos, Paulo Sergio Alves Bueno, Felipe de Oliveira Souza, Eduardo J. Pilau, Lillian Barros, Jurandir F. Comar, et al.

    Schematic representation of the action mechanisms and phytochemicals in Tamarindus indica waste for managing diabetes and obesity.


  • Copaiba essential oil carried in a self-nanoemulsifying drug delivery system improves adjuvant-induced arthritis in rats

    by Ana Paula Ames-Sibin, Any Carolina Chagas-Almeida, Ana Beatriz P Souza, Ana Paula M Andrade, Juliana C Castro, Sabrina B S Ferreira, Francielli Maria S Silva-Comar, Roberto K N Cuman, Marcos L Bruschi, Maria Raquel M Natali, et al.

    Objectives: Copaiba essential oil (CEO) is obtained through the distillation of copaiba balsam and has been used in the traditional medicine to treat inflammatory conditions. However, the highly lipophilic nature of CEO restricts its pharmaceutical use. This study evaluated the effect of CEO, carried in a self-nanoemulsifying drug delivery system (SNEDDS), on articular and systemic inflammation and liver changes in Holtzman rats with Freund’s adjuvant-induced arthritis. Methods: Healthy and arthritic rats received orally for 18 days the non-formulated CEO and the one carried in a self-nanoemulsifying drug delivery system (FSNEDDS), both at doses of 50 and 100 mg/kg. The oral bioavailability of FSNEDDS was determined in healthy rats by quantifying the levels of β-caryophyllene in the plasma. Key findings: FSNEDDS exhibited more than three times greater oral bioavailability compared to non-formulated CEO. This phenomenon allowed FSNEDDS (100 mg/kg) to effectively reduce adjuvant-induced articular and systemic inflammation and oxidative stress in arthritic rats at a dose four times lower than copaiba balsam and β-caryophyllene. Furthermore, FSNEDDS did not alter the serum markers of liver damage, hepatic morphometry, and liver gluconeogenesis in healthy rats. Conclusion: FSNEDDS was effective against arthritis in rats, and unlike copaiba balsam, it does not exhibit hepatotoxicity, suggesting it could serve as a phytotherapeutic alternative in the treatment of rheumatoid arthritis.


  • Open Access

    Biotechnological, Nutritional, and Therapeutic Applications of Quinoa (Chenopodium quinoa Willd.) and Its By-Products: A Review of the Past Five-Year Findings

    by Rhaira Fernanda Ayoub Casalvara, Bruna Mayara Roldão Ferreira, José Eduardo Gonçalves, Natália Ueda Yamaguchi, Adelar Bracht, Lívia Bracht, Jurandir Fernando Comar, Anacharis Babeto de Sá-Nakanishi, Cristina Giatti Marques de Souza, Rafael Castoldi, et al.

    This study aimed to provide an updated critical review of the nutritional, therapeutic, biotechnological, and environmental aspects involved in the exploitation of Chenopodium quinoa Willd and its biowastes. Special attention was devoted to investigations of the therapeutic and nutritional properties of different parts and varieties of quinoa as well as of the use of the biowaste resulting from the processing of grain. Studies published from 2018 onward were prioritized. Extracts and fractions obtained from several Chenopodium quinoa matrices showed antioxidant, antidiabetic, immunoregulatory, neuroprotective, and antimicrobial effects in in vitro and in vivo models and some clinical studies. The activities were attributed to the presence of phytochemicals such as polyphenols, saponins, peptides, polysaccharides, and dietary fibers. Quinoa wastes are abundant and low-cost sources of bioactive molecules for the development of new drugs, natural antioxidants, preservatives, dyes, emulsifiers, and carriers for food and cosmetics applications. Among the demands to be fulfilled in the coming years are the following: (1) isolation of new bioactive phytochemicals from quinoa varieties that are still underexploited; (2) optimization of green approaches to the sustainable recovery of compounds of industrial interest from quinoa by-products; and (3) well-conducted clinical trials to attest safety and efficacy of extracts and compounds.


  • Effects of a high-fat low-carbohydrate diet under different energy conditions on glucose homeostasis and fatty liver development in rats and on gluconeogenesis in the isolated perfused liver

    by Mateus José de Oliveira, Evelyn Silva Moreira, Naiara Cristina Lucredi, Carla Indianara Bonetti, Anacharis Babeto de Sá-Nakanishi, Jurandir Fernando Comar, Adelar Bracht, Lívia Bracht

    The beneficial effects of high-fat low-carbohydrate (HFLC) diets on glucose metabolism have been questioned and their effects on liver metabolism are not totally clear. The aim of this work was to investigate the effects of an HFLC diet under different energy conditions on glucose homeostasis, fatty liver development, and hepatic gluconeogenesis using the isolated perfused rat liver. HFLC diet (79% fat, 19% protein, and 2% carbohydrates in Kcal%) was administered to rats for 4 weeks under three conditions: ad libitum (hypercaloric), isocaloric, and hypocaloric (energy reduction of 20%). Fasting blood glucose levels and total fat in the liver were higher in all HFLC diet rats. Oral glucose tolerance was impaired in isocaloric and hypercaloric groups, although insulin sensitivity was not altered. HFLC diet also caused marked liver metabolic alterations: higher gluconeogenesis rate from lactate and a reduced capacity to metabolize alanine, the latter effect being more intense in the hypocaloric condition. Thus, even when HFLC diets are used for weight loss, our data imply that they can potentially cause harmful consequences for the liver.


  • Characterization and bioactivities of coffee husks extract encapsulated with polyvinylpyrrolidone

    by Anielle de Oliveira, Thaysa F.M. Moreira, Beatriz Paes Silva, Grazielle Oliveira, Valéria Maria C. Teixeira, Lycio S. Watanabe, Suzana Lucy Nixdorf, Luana Eloísa Leal, Luiz Gustavo A. Pessoa, Flavio Augusto V. Seixas, et al.